Indication

GLP-1 medications for Obstructive sleep apnea with obesity

GLP-1 medications for Obstructive sleep apnea with obesity, with sourced prices, shortage reports and study results.

Last checked · Oct 3, 2026 UTC

1approved

Approved for this use

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

GIP/GLP-1

Tirzepatide

Mounjaro, Zepbound

Subcutaneous injection · Once weekly

FDA shortage report

Published entry quote

$299-$449/28 days

Zepbound KwikPen (multi-dose pen) · LillyDirect (Eli Lilly)

Checked Sep 30, 2026

Price conditions

self-pay cash, by dose ($299 / $399 / $449)

Four weekly doses per pen; pen needles must be purchased separately. $299 at 2.5 mg, $399 at 5 mg, and $449 at higher doses under the Self Pay Journey offer with a refill within 45 days.

28-day supply

Checked Sep 30, 2026. Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.